Molecular Diagnostics: Page 5

Velsera, Solaris Health partner to expand genetic testing access to urology practices
By LabPulse.com staff writers
Healthcare technology company Velsera and urological services platform Solaris Health are collaborating to expand access to genetic testing to cancer patients and their physicians at urology practices affiliated with Solaris.
November 8, 2023
Lab Test Tube Dna Blood Social
Genomics England, Oxford Nanopore to collaborate on sequencing rare diseases
By Matt Limb
Genomics England and Oxford Nanopore Technologies have announced a strategic research partnership to resolve undiagnosed rare disease cases.
November 7, 2023
Cell Gene Therapy Dna Social
Illumina unveils new version of liquid biopsy assay
By Matt Limb
Genomics company Illumina has announced a new generation of its distributed liquid biopsy assay for the genomic profiling of solid tumors.
November 8, 2023
Cancer Therapy Targeted Social
CRISPR Therapeutics to present data from gene therapy programs at AHA Scientific Sessions
By LabPulse.com staff writers
Biopharmaceutical company CRISPR Therapeutics will present preclinical data from its investigational gene therapy treatment programs for cardiovascular disease at the AHA Scientific Sessions 2023 in Philadelphia on November 11.
November 6, 2023
Crispr Cas9 Gene Editing Social
Blood test for biomarker offers route to affordable cancer screening
By Nick Paul Taylor
Researchers have developed a sensitive blood test for a highly specific biomarker of multiple common tumors, laying the groundwork for a product that could improve cancer screening.
November 6, 2023
Blood Test Samples Lab Social
Oxford Nanopore partners with Fabric Genomics on assessment of genetic disease in children
By Nick Paul Taylor
Oxford Nanopore Technologies and Fabric Genomics have teamed up to provide a sequencing analysis platform for neonatal and pediatric intensive care units.
November 1, 2023
Child Hospital Social
Vertex Pharmaceuticals, CRISPR Therapeutics gene-editing therapy to undergo FDA advisory committee review
By LabPulse.com staff writers
An FDA advisory committee is scheduled to meet on October 31 to discuss and make recommendations on Vertex Pharmaceuticals' and CRISPR Therapeutics’ CRISPR-Cas9 gene-editing-based therapy, exagamglogene autotemcel.
October 30, 2023
Fda Sign Dc Social
US ambassador visits NGS laboratory in India
By LabPulse.com staff writers
There is growing bilateral cooperation in cancer research, prevention, control, and management, where leaders said they looked forward to the launch of the India-U.S. Cancer Dialogue.
October 30, 2023
Dna Genome Gene Targeted Social
Software reduces DANGER of CRISPR-Cas9 by shedding light on off-target edits
By Nick Paul Taylor
A new software can improve the safety and utility of CRISPR-Cas9 gene editing by detecting off-target changes and eliminating the need for reference genomes, according to a paper published in Bioinformatics Advances.
October 27, 2023
Crispr Cas9 Gene Editing Social
FDA to discuss phaseout enforcement discretion for LDTs
By Liz Carey
In relation to its proposed medical device rule targeting laboratory developed tests (LDTs), the U.S. Food and Drug Administration (FDA) will hold a webinar Tuesday, October 31, at 1 p.m. EST.
October 26, 2023
Lab Vacutainer Test Tube Social
Polygenic risk score tests don’t meet expectations, U.K. study shows
By Matt Limb
Polygenic risk scores “perform poorly in screening and prediction of common disease,” failing to identify nearly 90% of patients who develop disease, according to a U.K. study.
October 26, 2023
Dna Sequencing Genome Social
Pharma companies back project to create largest African ancestry genomics research database
By Nick Paul Taylor
AstraZeneca, Novo Nordisk, Regeneron, and Roche have backed a project to create the largest African ancestry genomics research database.
October 25, 2023
Dna Genome Gene Targeted Social
Previous Page
Page 5 of 193
Next Page